Topical alpha-interferon in recurrent conjunctival papilloma

Acta Ophthalmol Scand. 2003 Apr;81(2):193-6. doi: 10.1034/j.1600-0420.2003.00043.x.

Abstract

Purpose: To report the effect of topical alpha-interferon (alpha-IF) in two cases of recurrent conjunctival papillomas.

Methods: One patient with a conjunctival papilloma and one patient with a limbus-based papilloma were treated with excision and cryotherapy. Recurrences included one in situ carcinoma. Retreatment included systemic and topical alpha-IF.

Results: In Case 1, the papillomas regressed with systemic alpha-IF followed by topical application of alpha-IF (2.8 x 106 U) for 1 year against recurrence. In Case 2, the papillomas disappeared with topical alpha-IF over 1 year. No recurrences were seen during follow-up (84 and 91 months, respectively). The possible side effect of topical alpha-IF was superficial keratitis. Retrospective polymerase chain reaction tests for HPV were positive and showed type 6 in Case 1 and type 33 in Case 2.

Conclusion: Topical alpha-IF can be used as adjuvant therapy in recurrent conjunctival papillomas.

Publication types

  • Case Reports

MeSH terms

  • Administration, Topical
  • Adult
  • Aged
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / adverse effects
  • Conjunctival Neoplasms / drug therapy*
  • Conjunctival Neoplasms / pathology
  • Eye Neoplasms / drug therapy*
  • Eye Neoplasms / pathology
  • Female
  • Humans
  • Interferon-alpha / administration & dosage*
  • Interferon-alpha / adverse effects
  • Keratitis / chemically induced
  • Male
  • Neoplasm Recurrence, Local / drug therapy*
  • Neoplasm Recurrence, Local / pathology
  • Papilloma / drug therapy*
  • Papilloma / pathology

Substances

  • Antineoplastic Agents
  • Interferon-alpha